Evommune (EVMN) Non-Current Assets (2024 - 2026)

Evommune (EVMN) has 3 years of Non-Current Assets data on file, last reported at $106.6 million in Q1 2026.

• Quarterly Non-Current Assets changed N/A year-over-year to $106.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $182.7 million (changed N/A YoY) and the FY2025 annual result came in at $71.5 million, up 3357.57% from the prior year.
• Non-Current Assets rose to $106.6 million in Q1 2026 per EVMN's latest filing, from $71.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $106.6 million in Q1 2026 and bottomed at $2.1 million in Q4 2024.
• The 3-year median for Non-Current Assets is $37.0 million (2025), against an average of $45.7 million.
• Peak annual rise in Non-Current Assets reached 3357.57% in 2025, while the deepest fall reached 3357.57% in 2025.
• Tracing EVMN's Non-Current Assets over 3 years: stood at $2.1 million in 2024, then surged by 3357.57% to $71.5 million in 2025, then soared by 49.16% to $106.6 million in 2026.
• Per Business Quant, the three latest EVMN Non-Current Assets figures stand at $106.6 million (Q1 2026), $71.5 million (Q4 2025), and $2.6 million (Q3 2025).

Peer Comparison